

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in ankylosing spondylitis:... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1512/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1512" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in ankylosing spondylitis: understanding the disease and management" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in ankylosing spondylitis: understanding the disease and management.">
            <meta name="og:description" content="Read the latest article version by Leticia Garcia-Montoya, Hanna Gul, Paul Emery, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="16283">
            <meta name="article-id" content="14956">
            <meta name="dc.title" content="Recent advances in ankylosing spondylitis: understanding the disease and management">
            <meta name="dc.description" content="The term spondyloarthritis refers to a group of immune-mediated diseases characterised by inflammation of the axial skeleton, peripheral joints, and entheses. Ankylosing spondylitis (AS) is the most common and characteristic of these entities and even though it was first described over two centuries ago, the understanding of the underlying disease mechanism remains incomplete. It is known that around 40% of patients with AS have subclinical bowel inflammation, suggesting that the origin of the disease could be in the gut. Also, more genes and new molecules have demonstrated a role in the pathogenesis of AS. In this review, we analyse the latest therapies for spondyloarthritis and the most relevant discoveries over the last three years, together with their implications for different aspects of the disease.">
            <meta name="dc.subject" content="Ankylosing spondylitis, spondyloarthritis, spondyloarthropathy, management, pathogenesis">
            <meta name="dc.creator" content="Garcia-Montoya, Leticia">
            <meta name="dc.creator" content="Gul, Hanna">
            <meta name="dc.creator" content="Emery, Paul">
            <meta name="dc.date" content="2018/09/21">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14956.1">
            <meta name="dc.source" content="F1000Research 2018 7:1512">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Ankylosing spondylitis">
            <meta name="prism.keyword" content="spondyloarthritis">
            <meta name="prism.keyword" content="spondyloarthropathy">
            <meta name="prism.keyword" content="management">
            <meta name="prism.keyword" content="pathogenesis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/09/21">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1512">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14956.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1512">
            <meta name="citation_title" content="Recent advances in ankylosing spondylitis: understanding the disease and management">
            <meta name="citation_abstract" content="The term spondyloarthritis refers to a group of immune-mediated diseases characterised by inflammation of the axial skeleton, peripheral joints, and entheses. Ankylosing spondylitis (AS) is the most common and characteristic of these entities and even though it was first described over two centuries ago, the understanding of the underlying disease mechanism remains incomplete. It is known that around 40% of patients with AS have subclinical bowel inflammation, suggesting that the origin of the disease could be in the gut. Also, more genes and new molecules have demonstrated a role in the pathogenesis of AS. In this review, we analyse the latest therapies for spondyloarthritis and the most relevant discoveries over the last three years, together with their implications for different aspects of the disease.">
            <meta name="citation_description" content="The term spondyloarthritis refers to a group of immune-mediated diseases characterised by inflammation of the axial skeleton, peripheral joints, and entheses. Ankylosing spondylitis (AS) is the most common and characteristic of these entities and even though it was first described over two centuries ago, the understanding of the underlying disease mechanism remains incomplete. It is known that around 40% of patients with AS have subclinical bowel inflammation, suggesting that the origin of the disease could be in the gut. Also, more genes and new molecules have demonstrated a role in the pathogenesis of AS. In this review, we analyse the latest therapies for spondyloarthritis and the most relevant discoveries over the last three years, together with their implications for different aspects of the disease.">
            <meta name="citation_keywords" content="Ankylosing spondylitis, spondyloarthritis, spondyloarthropathy, management, pathogenesis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Leticia Garcia-Montoya">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK">
            <meta name="citation_author_institution" content="NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK">
            <meta name="citation_author" content="Hanna Gul">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK">
            <meta name="citation_author_institution" content="NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK">
            <meta name="citation_author" content="Paul Emery">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK">
            <meta name="citation_author_institution" content="NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK">
            <meta name="citation_publication_date" content="2018/09/21">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1512">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14956.1">
            <meta name="citation_firstpage" content="1512">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1512/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1512.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=16283 /> <input type=hidden id=articleId name=articleId value=14956 /> <input type=hidden id=xmlUrl value="/articles/7-1512/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1512-v1.xml"> <input type=hidden id=article_uuid value=462243f8-93f7-46ce-8c7c-42e495053dcb /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in ankylosing spondylitis: understanding the disease and management"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14956.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14956.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1512"
  },
  "headline": "Recent advances in ankylosing spondylitis: understanding the disease and management",
  "datePublished": "2018-09-21T10:16:15",
  "dateModified": "2018-09-21T10:16:15",
  "author": [
    {
      "@type": "Person",
      "name": "Leticia Garcia-Montoya"
    },    {
      "@type": "Person",
      "name": "Hanna Gul"
    },    {
      "@type": "Person",
      "name": "Paul Emery"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The term spondyloarthritis refers to a group of immune-mediated diseases characterised by inflammation of the axial skeleton, peripheral joints, and entheses. Ankylosing spondylitis (AS) is the most common and characteristic of these entities and even though it was first described over two centuries ago, the understanding of the underlying disease mechanism remains incomplete. It is known that around 40% of patients with AS have subclinical bowel inflammation, suggesting that the origin of the disease could be in the gut. Also, more genes and new molecules have demonstrated a role in the pathogenesis of AS. In this review, we analyse the latest therapies for spondyloarthritis and the most relevant discoveries over the last three years, together with their implications for different aspects of the disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1512",
            "name": "Recent advances in ankylosing spondylitis: understanding the disease..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in ankylosing spondylitis: understanding the disease... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=16283 data-id=14956 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14956.1" data-recommended="" data-doi="10.12688/f1000research.14956.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1512/v1/pdf?article_uuid=462243f8-93f7-46ce-8c7c-42e495053dcb" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14956-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14956-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14956-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Garcia-Montoya L, Gul H and Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1512 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14956.1" target=_blank>https://doi.org/10.12688/f1000research.14956.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14956-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14956 id=track-article-signin-14956 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14956?target=/articles/7-1512">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16283 /> <input name=articleId type=hidden value=14956 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in ankylosing spondylitis: understanding the disease and management</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:L.garcia-montoya@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Leticia Garcia-Montoya</span></a><a href="https://orcid.org/0000-0002-1806-7532" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1806-7532</div><sup>1,2</sup>,&nbsp;</span><span class="">Hanna Gul<sup>1,2</sup>,&nbsp;</span><span class="">Paul Emery<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:L.garcia-montoya@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Leticia Garcia-Montoya</span></a><a href="http://orcid.org/0000-0002-1806-7532" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1806-7532</div><sup>1,2</sup>,&nbsp;</span><span class="">Hanna Gul<sup>1,2</sup>,&nbsp;</span><span class="">Paul Emery<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 21 Sep 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14956.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK<br/> <sup>2</sup> NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK<br/> <p> <div class=margin-bottom> Leticia Garcia-Montoya <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Project Administration, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Hanna Gul <br/> <span>Roles: </span> Visualization, Writing  Review & Editing </div> <div class=margin-bottom> Paul Emery <br/> <span>Roles: </span> Conceptualization, Supervision, Visualization, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=39045-38200></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=39046-38201></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The term spondyloarthritis refers to a group of immune-mediated diseases characterised by inflammation of the axial skeleton, peripheral joints, and entheses. Ankylosing spondylitis (AS) is the most common and characteristic of these entities and even though it was first described over two centuries ago, the understanding of the underlying disease mechanism remains incomplete. It is known that around 40% of patients with AS have subclinical bowel inflammation, suggesting that the origin of the disease could be in the gut. Also, more genes and new molecules have demonstrated a role in the pathogenesis of AS. In this review, we analyse the latest therapies for spondyloarthritis and the most relevant discoveries over the last three years, together with their implications for different aspects of the disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Ankylosing spondylitis, spondyloarthritis, spondyloarthropathy, management, pathogenesis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Leticia Garcia-Montoya (<a href="mailto:L.garcia-montoya@leeds.ac.uk">L.garcia-montoya@leeds.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Leticia Garcia-Montoya </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> PE has undertaken clinical trials and provided expert advice to Abbvie, BMS, Gilead, MSD, Novartis, Pfizer, Roche, Samsung, Sandoz, UCB, and Lilly. LGM and HG declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Garcia-Montoya L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Garcia-Montoya L, Gul H and Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1512 (<a href="https://doi.org/10.12688/f1000research.14956.1" target=_blank>https://doi.org/10.12688/f1000research.14956.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 21 Sep 2018, <b>7</b>(F1000 Faculty Rev):1512 (<a href="https://doi.org/10.12688/f1000research.14956.1" target=_blank>https://doi.org/10.12688/f1000research.14956.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 21 Sep 2018, <b>7</b>(F1000 Faculty Rev):1512 (<a href="https://doi.org/10.12688/f1000research.14956.1" target=_blank>https://doi.org/10.12688/f1000research.14956.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d757e179>Introduction</h2><p class="" id=d757e182>Ankylosing spondylitis (AS) is a chronic immune-mediated inflammatory arthritis included in the so-called group of spondyloarthritis (SpA). It typically develops in males in their third decade of life and affects mainly the axial skeleton and the sacroiliac joints. Although the oldest descriptions date from the time of Galen, it was not until the 19th century that the disease could be accurately diagnosed on the basis of reports by Vladimir Bekhterev, Adolph Strmpell, and Pierre Marie. The HLA-B27 allele is known to have a strong association with the disease<sup><a href="#ref-1">1</a></sup>; however, other genes play a part in its development. The discovery of several inflammatory pathways led to the era of the biologic therapies, which meant a revolution in the treatment and prognosis of AS. Tumour necrosis factor inhibitors (TNFis) were the first ones to be approved, but in the last few years the interleukin-17 (IL-17)/IL-23 axis has gained relevance, culminating in the licence of new biological disease-modifying antirheumatic drugs (bDMARDs) blocking IL-17.</p><p class="" id=d757e189>In spite of all of these advances, the disease mechanisms underlying the disease are not fully understood and new information concerning the pathogenesis, triggers, and the outcome of new treatments continues to appear. In this review, we will focus on the advances of the last three years regarding the above aspects of AS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e195>Genetics</h2><p class="" id=d757e198>AS is considered an inherited disease, as over 90% of the risk for its development relies on genes<sup><a href="#ref-2">2</a></sup>. However, the HLA-B27 allele accounts for only 20% of the genetic effect<sup><a href="#ref-1">1</a></sup>. Other alleles, especially HLA-B, are thought to play an important role in the disease: HLA-B*13:02, HLA-B*40:01, HLA-B*47, and HLA-B*51 are some examples<sup><a href="#ref-3">3</a></sup>. The most significant discovery of the last three years has been the interaction of ERAP1, the protein endoplasmic reticulum aminopeptidase 1, with the HLA-B alleles, resulting in a higher risk of developing AS. The main variant of the gene (rs30187, K528R) interacts only with the HLA-B27 allele, and in patients who are HLA-B27 negative, ERAP1 interacts with the HLA-B40 allele<sup><a href="#ref-4">4</a></sup>. The mechanism underlying the increased risk remains unclear; nevertheless, it is known that the presence of this gene is not related to the radiographic severity of the disease<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d757e221>A recent study reported that a lower copy number of the <i>TLR7</i> gene was a marker for susceptibility to AS in males but behaves as a protective factor in women<sup><a href="#ref-6">6</a></sup>. Ruan <i>et al</i>.<sup><a href="#ref-7">7</a></sup> found that genetic polymorphisms of IL-12B (rs6871626) and IL-6R (rs4129267) were associated with an increased risk of AS independently of gender and also could function as biomarkers for diagnosis and prognosis.</p><p class="" id=d757e238>Genome-wide association studies have shown that the T helper 17/23 (Th17/23) axis and its multiple genetic polymorphisms are involved not only in AS but also in inflammatory bowel disease (IBD) and psoriasis, supporting the hypothesis that there is a common underlying pathogenic mechanism and that the microbiome seems to be implicated in the development of the diseases<sup><a href="#ref-8">8</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e248>Pathogenesis</h2><p class="" id=d757e251>How HLA-B27 initiates AS is unknown, and, after many years, some of the earliest hypotheses are still being investigated. The original hypothesis, called the arthritogenic peptide theory, suggests that the presentation of either bacterial peptides by HLA-B27 or self-mimicking HLA-B27-binding peptides from certain bacteria could initiate a cell-mediated immune reaction leading to AS<sup><a href="#ref-9">9</a></sup>. The second one is the unfolded protein response hypothesis, which suggests that HLA-B27 tends to misfold and accumulate in the endoplasmic reticulum, triggering a stress response that results in the release of IL-23<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. However, a new study<sup><a href="#ref-12">12</a></sup> has questioned these two theories, claiming that the arthritogenic peptide theory should be reassessed in terms of quantitative changes concerning self-peptide presentation and T-cell selection. It also stated that the absolute binding preferences of HLA-B27 allotypes are not sufficient to explain the association of the disease.</p><p class="" id=d757e269>The third hypothesis is the HLA-B27 homodimer model<sup><a href="#ref-13">13</a></sup>, which supports the view that HLA-B27 homodimers have an abnormal interaction with natural killer (NK) and CD4 T cells. Unlike the heterodimeric form of HLA-B27, the homodimer is able to bind to certain killer cell immunoglobulin-like receptors (KIRs), which are expressed on NK cells and T cells, causing the release of IL-17<sup><a href="#ref-14">14</a><a href="#ref-16">16</a></sup>. Ridley <i>et al</i>.<sup><a href="#ref-17">17</a></sup> have proven that CD41 T cells upregulate the expression of KIR-3DL2 on the cell surface and that the binding of this receptor to HLA-B27 potentiates T-cell survival and Th17 cell differentiation. Th17 cells are a type of T-helper lymphocyte which produces IL-17<sup><a href="#ref-18">18</a></sup>, a cytokine able to increase T-cell priming and stimulate immune cells such as fibroblasts and macrophages promoting the release of IL-6, TNF-, and other chemokines<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d757e299>Oppmann <i>et al</i>. found that IL-23 is one of the triggers of the Th17 response<sup><a href="#ref-20">20</a></sup>. This molecule is a pro-inflammatory cytokine that seems to play an important part in stabilising Th17 cell phenotype through the transcription factor Blimp-1 (Prdm1)<sup><a href="#ref-21">21</a></sup>, which is associated with Crohns disease<sup><a href="#ref-22">22</a></sup>. Th17 cells are commonly found in the intestinal lamina propria of the gut<sup><a href="#ref-23">23</a></sup> and their instability can be induced by exposure to certain bacteria, leading to the transition of Th17 cells into regulatory T (Treg) cells<sup><a href="#ref-24">24</a></sup>. Maxwell <i>et al</i>.<sup><a href="#ref-25">25</a></sup> also suggested that IL-23 promotes the accumulation of Treg cells in the bowel, some of which probably were Th17 previously<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e343>Microbiome</h2><p class="" id=d757e346>Gut mucosal inflammation is estimated to be present in 70% of patients with AS<sup><a href="#ref-28">28</a></sup>, progressing to clinical IBD in 5% of cases. Crohns disease and ulcerative colitis are characterised by having gut dysbiosis (a qualitative or quantitative microbial imbalance) which is also seen in AS<sup><a href="#ref-29">29</a></sup>. The Ghent inflammatory arthritis and spondylitis cohort (GIANT) studies strongly support the concept that there is a relationship between gut inflammation and the pathogenesis of AS<sup><a href="#ref-30">30</a><a href="#ref-32">32</a></sup>. One of the theories to explain it is that a constant antigenic stimulation can activate T cells and this might be responsible for chronic bowel inflammation<sup><a href="#ref-33">33</a></sup>. Other studies suggest that patients with AS (and their first-degree relatives) have a high gut permeability, which increases their exposure to gut microbes<sup><a href="#ref-34">34</a></sup>. In addition, animal studies proved that HLA-B27 alone was insufficient to develop AS, since transgenic rats that had been raised in a germ-free environment did not develop features of SpA<sup><a href="#ref-35">35</a></sup>. In the last few years, investigators have focussed on detecting pathogens as triggers for AS. <i>Klebsiella pneumoniae</i> was the first to be reported<sup><a href="#ref-36">36</a></sup>: this bacterium is thought to carry an antigen that resembles a molecule coded by the <i>HLA-B27</i> gene; however, the mechanism is not fully understood and other studies have stated that its involvement in AS is unlikely. Other relevant families of bacteria that have been associated with the development of AS are <i>Lachnospiraceae</i>, <i>Prevotellaceae</i>, <i>Rikenellaceae</i>, <i>Porphyromonadaceae</i>, and <i>Bacteroidaceae</i>. Non-gut bacteria are also thought to be involved: periodontal disease has become a possible target as anti-<i>Porphyromonas gingivalis</i> and anti-<i>Prevotella intermedia</i> antibodies are detected in high titres in patients with SpA<sup><a href="#ref-37">37</a></sup>. Some studies even suggest that chronic periodontitis is associated with severe spinal dysmobility in AS<sup><a href="#ref-38">38</a></sup>. Nevertheless, it is still an area of investigation, as recently published results contradict these findings<sup><a href="#ref-39">39</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e425>Gender differences</h2><p class="" id=d757e428>Evidence gained in the last few years suggests that AS affects men and women differently. Landi <i>et al</i>.<sup><a href="#ref-40">40</a></sup> analysed a sample of 2,044 patients with AS and reported that disease commences earlier in men but that the diagnosis is usually more delayed than in women. Men have lower disease activity measured by Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Assessment of SpondyloArthritis international Society (ASAS)-endorsed Disease Activity Score (ASDAS) and a better quality of life (Ankylosing Spondylitis Quality of Life Questionnaire, or ASQol) but have worse spinal mobility (Bath Ankylosing Spondylitis Metrology Index, or BASMI) and a more serious radiologic progression (Bath Ankylosing Spondylitis Radiology Index, or BASRI). In contrast, women usually have more peripheral arthritis and an increased prevalence of arthritis, dactylitis, and enthesitis combined with a worse quality of life and a worse response to anti-TNF treatment<sup><a href="#ref-41">41</a></sup>. This contradicts the results reported by Webers <i>et al</i>.<sup><a href="#ref-42">42</a></sup>, who agreed that men had more radiographic damage and a better quality of life but did not find differences in disease activity or physical function. However, the authors analysed only 216 patients.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e453>Therapies</h2><p class="" id=d757e456>Since 2015, there has been remarkable progress concerning the therapeutic management of AS. New treatments and strategies have paralleled the description of new pathogenic mechanisms. <a href="#T1">Table 1</a> summarises the most relevant drugs and their mechanism of action; some are still under investigation<sup><a href="#ref-43">43</a><a href="#ref-55">55</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Novel approaches for the management of ankylosing spondylitis.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d757e480 class=n-a></a><thead><a name=d757e482 class=n-a></a><tr><a name=d757e484 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d757e486 class=n-a></a>Therapy</th><th align=left colspan=1 rowspan=1 valign=top><a name=d757e489 class=n-a></a>Reference</th><th align=left colspan=1 rowspan=1 valign=top><a name=d757e492 class=n-a></a>Mechanism of action</th><th align=left colspan=1 rowspan=1 valign=top><a name=d757e495 class=n-a></a>Current status</th></tr></thead><tbody><a name=d757e500 class=n-a></a><tr><a name=d757e502 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e504 class=n-a></a>CT-P13<br class=br>(infliximab biosimilar) </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e509 class=n-a></a><a href="#ref-43">43</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e513 class=n-a></a>Anti-TNF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e516 class=n-a></a>Approved for use in AS</td></tr><tr><a name=d757e520 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e522 class=n-a></a>SB4<br class=br>(etanercept biosimilar) </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e527 class=n-a></a><a href="#ref-44">44</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e531 class=n-a></a>Anti-TNF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e534 class=n-a></a>Approved for use in AS </td></tr><tr><a name=d757e538 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e540 class=n-a></a>Secukinumab </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e543 class=n-a></a><a href="#ref-45">45</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e547 class=n-a></a>Anti-IL-17A</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e550 class=n-a></a>Approved for use in AS</td></tr><tr><a name=d757e554 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e556 class=n-a></a>Ixekizumab </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e559 class=n-a></a><a href="#ref-46">46</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e563 class=n-a></a>Anti-IL-17A</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e566 class=n-a></a>Under investigation. Primary endpoints met.</td></tr><tr><a name=d757e570 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e572 class=n-a></a>Brodalumab </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e575 class=n-a></a><a href="#ref-47">47</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e579 class=n-a></a>Anti-IL-17R</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e582 class=n-a></a>Not approved owing to safety issues</td></tr><tr><a name=d757e587 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e589 class=n-a></a>Ustekinumab </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e592 class=n-a></a><a href="#ref-48">48</a>,<a href="#ref-49">49</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e599 class=n-a></a>Anti-IL-12/IL-23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e602 class=n-a></a>Not approved owing to lack of efficacy</td></tr><tr><a name=d757e606 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e608 class=n-a></a>ABT-122 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e611 class=n-a></a><a href="#ref-50">50</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e615 class=n-a></a>Anti-IL-17A/TNF-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e618 class=n-a></a>Under investigation. Successful phase II clinical<br class=br>trials</td></tr><tr><a name=d757e624 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e626 class=n-a></a>COVA322 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e629 class=n-a></a><a href="#ref-51">51</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e633 class=n-a></a>Anti-IL-17A/TNF- </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e636 class=n-a></a>Not approved owing to safety issues</td></tr><tr><a name=d757e640 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e642 class=n-a></a>CBP30 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e645 class=n-a></a><a href="#ref-52">52</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e649 class=n-a></a>CBP/p300 bromodomain inhibition</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e652 class=n-a></a>Future trials announced</td></tr><tr><a name=d757e656 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e658 class=n-a></a>Sarilumab</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e661 class=n-a></a><a href="#ref-53">53</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e665 class=n-a></a>Anti-IL-6R</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e668 class=n-a></a>Not approved owing to lack of efficacy</td></tr><tr><a name=d757e672 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d757e674 class=n-a></a>Tofacitinib</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e677 class=n-a></a><a href="#ref-54">54</a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e681 class=n-a></a>JAK inhibitor</td><td align=left colspan=1 rowspan=1 valign=top><a name=d757e684 class=n-a></a>Under investigation. Successful phase II clinical<br class=br>trials</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d757e694 class=n-a></a><p id=d757e696> AS, ankylosing spondylitis; IL, interleukin; JAK, Janus kinase; TNF, tumour necrosis factor.</p></div></div></div><div class=section><a name=d757e702 class=n-a></a><h3 class=section-title>Tumour necrosis factor inhibitors</h3><p class="" id=d757e707>The first bDMARDs were approved several years ago. As the patents of some of these drugs were closer to expiration, pharmaceutical companies focused their interest on developing more affordable drugs. CT-P13, the infliximab biosimilar, was the first one to be released<sup><a href="#ref-43">43</a></sup>, followed by Benepali (SB4), the etanercept biosimilar, in 2016<sup><a href="#ref-56">56</a></sup>. Multiple trials endorse the similar safety and efficacy of CP-P13 and infliximab not only in patients with AS but also in the treatment of rheumatoid arthritis (RA). The PLANETAS study reported comparable results for patients with AS regarding ASAS20 and ASAS40<sup><a href="#ref-57">57</a></sup>. The extension of the study showed that switching from infliximab to its biosimilar did not imply negative effects on safety or efficacy<sup><a href="#ref-58">58</a></sup>. These findings were also confirmed in the PLANETRA study, carried out in patients with RA<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. In regard to Benepali (SB4), the most important efficacy and safety studies have been carried out in RA, showing results similar to those obtained with Enbrel<sup><a href="#ref-44">44</a></sup>. As far as therapy switching is concerned, the safety and efficacy are maintained after switching from Enbrel to Benepali in patients with RA<sup><a href="#ref-61">61</a></sup>, and a study is taking place in Germany to assess this transition in patients with AS<sup><a href="#ref-62">62</a></sup>.</p></div><div class=section><a name=d757e747 class=n-a></a><h3 class=section-title>Interleukin inhibitors</h3><p class="" id=d757e752>The approval of secukinumab, a fully human monoclonal antibody able to neutralise IL-17A, has been a major advance in the treatment of AS<sup><a href="#ref-45">45</a></sup>. Patients with AS are known to have high levels of this interleukin<sup><a href="#ref-63">63</a></sup>, which is critically involved in the pathogenesis of the disease. IL-23 is secreted by antigen-presenting cells and stimulates Th17 cells, which are defined by their production of IL-17 cytokines<sup><a href="#ref-64">64</a></sup>.</p><p class="" id=d757e767>Two double-blind, placebo-controlled, phase III clinical trialsMEASURE 1<sup><a href="#ref-65">65</a></sup> and MEASURE 2<sup><a href="#ref-66">66</a></sup>reported a significant improvement in disease activity in patients with AS with effects sustained over 2 years; this was combined with a good safety profile. Pavelka <i>et al</i>.<sup><a href="#ref-67">67</a></sup> recently published the results of MEASURE 3, a randomised, double-blind, phase III trial in patients with active AS. In accordance with previous studies, a significant improvement was reported in the 16-week follow-up compared with placebo and this was sustained until week 52. The patients initially on placebo, who were randomly assigned on week 16, also experienced improvement through week 52. During this time, no major new adverse events were noted. In addition, MEASURE 5, another randomised, double-blind, phase III trial is ongoing. It is also comparing the safety and tolerability of secukinumab in patients with active AS versus placebo<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d757e789>Nevertheless, there are other drugs targeting IL-17. COAST-W<sup><a href="#ref-69">69</a></sup> is a phase III, randomised, double-blind, placebo-controlled trial assessing the effect of ixekizumab on radiographic axial SpA. Ixekizumab is also a fully human monoclonal antibody that binds to IL-17A. The first results show that the drug met all of the primary and secondary endpoints. Brodalumab, a monoclonal antibody neutralising IL-17R, proved its efficacy for psoriatic arthritis; however, development was paused after a higher incidence of suicidal ideation was noted<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d757e800>IL-23 is directly related to the development of enthesitis<sup><a href="#ref-70">70</a></sup>, and the IL-23/IL-17 axis occupies a central place in the pathogenesis of SpA. Ustekinumab is a human monoclonal antibody targeting the p40 subunit of IL-12 and IL-23. It is considered one of the most effective treatments for psoriasis<sup><a href="#ref-71">71</a></sup>; however, its efficacy in AS has not been as expected, and results have been contradictory: TOPAS, a prospective, open-label, single-arm, proof-of-concept clinical trial<sup><a href="#ref-72">72</a></sup>, reported a reduction of signs and symptoms in patients with active AS. In contrast, a phase III, multicentre, randomised, double-blind, placebo-controlled study<sup><a href="#ref-48">48</a></sup> evaluating the efficacy and safety of ustekinumab in the treatment of non-radiographic axial SpA had to end prematurely after a related study<sup><a href="#ref-49">49</a></sup> did not achieve the key points.</p><p class="" id=d757e824>In regard to future approaches, ABT-122, an immunoglobulin molecule targeting both IL-17A and TNF-, has recently demonstrated its efficacy in phase I and II trials for RA and psoriatic arthritis<sup><a href="#ref-50">50</a>,<a href="#ref-73">73</a></sup>; however, given the importance of IL-17 in the pathogenesis of AS, it is expected that trials in patients with AS will commence soon. COVA322<sup><a href="#ref-74">74</a></sup> is another dual agent, a fusion protein antibody able to bind TNF- and IL-17A. It was thought to be a promising therapy for AS; however, owing to safety issues in a trial for psoriatic arthritis, investigations have not gone further<sup><a href="#ref-51">51</a></sup>. CBP30<sup><a href="#ref-52">52</a></sup> is a selective inhibitor of CBP/p300 bromodomains able to suppress the production of cytokines by Th17 cells in patients with AS and healthy controls. Future trials with this molecule have been announced. Sarilumab, a fully human monoclonal antibody that blocks the -receptor of IL-6, demonstrated a lack of efficacy for the treatment of AS in the ALIGN study<sup><a href="#ref-53">53</a></sup>.</p></div><div class=section><a name=d757e852 class=n-a></a><h3 class=section-title>Janus kinase inhibitors</h3><p class="" id=d757e857>Tofacitinib, a Janus kinase (JAK) inhibitor, is also able to interfere in the inflammatory cascade of IL-17, IL-21, and IL-23. In a 16-week clinical trial (with 12 weeks of treatment and 4 weeks of washout period), van der Heijde <i>et al</i>. reported the superiority of the 5 mg dose twice a day versus placebo: 63% and 40% of patients, respectively, achieved ASAS20 after 12 weeks<sup><a href="#ref-54">54</a></sup>.</p><p class="" id=d757e867>An important aspect for biologic therapies is the cost. As more patients receive bDMARDs, healthcare systems have been forced to find new ways to cope financially: one cost-saving strategy is tapering. The 2016 update of ASAS-European League Against Rheumatism (ASAS-EULAR) recommendations for the management of axial AS<sup><a href="#ref-75">75</a></sup> suggested that patients in sustained remission are candidates to taper the dose of the drug. However, there is controversy regarding this approach because of conflicting results. One single-centre prospective study<sup><a href="#ref-76">76</a></sup> compared the evolution of two groups of patients: one receiving TNFis at the standard dose and another group with down-titration. After one year of treatment, the clinical outcomes were similar in the two arms but costs were significantly reduced in the latter group. Plasencia <i>et al</i>.<sup><a href="#ref-77">77</a></sup> previously reported similar results in a retrospective study comparing patients in Spain on tapering strategy versus patients on standard dose from the Netherlands. Even though the proportion of patients who maintained remission was similar, those in the tapering group had more flares than the patients receiving the standard dose. Regarding radiographic progression, Park <i>et al</i>.<sup><a href="#ref-78">78</a></sup> found that patients who had syndesmophytes at baseline had a more rapid radiographic progression if they received a tapering regime.</p></div><div class=section><a name=d757e894 class=n-a></a><h3 class=section-title>Other therapies</h3><p class="" id=d757e899>bDMARDs are not the only therapies that have been developed within the last few years. Fattahi <i>et al</i>.<sup><a href="#ref-79">79</a></sup> reported the results of a randomised, placebo-controlled trial of a new non-steroidal anti-inflammatory drug (NSAID): B-D-mannuronic acid. The 12-week ASAS response was similar to that obtained with naproxen, and the safety profile was considerably better; there were no renal side effects and gastrointestinal tolerability was good.</p><p class="" id=d757e909>There has also been controversy regarding the administration of NSAIDs. Wanders <i>et al</i>.<sup><a href="#ref-80">80</a></sup> reported that continuous administration of NSAIDs reduced radiographic progression in comparison with on-demand therapy, whereas more recently Sieper <i>et al</i>.<sup><a href="#ref-81">81</a></sup> found that continuous treatment with diclofenac for 2 years did not reduce radiographic progression compared with an on-demand administration.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e930>Biomarkers</h2><p class="" id=d757e933>C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are two acute-phase reactants that classically have been used to assess the presence of inflammation in patients. Unfortunately, they are not specific and the sensitivity is also low<sup><a href="#ref-82">82</a></sup>, especially in patients with non-radiographic axial SpA<sup><a href="#ref-83">83</a></sup> where acute-phase proteins remain within normal limits most of the time.</p><p class="" id=d757e944>Owing to the lack of a reliable test, many studies have tried to find a biologic marker capable of predicting a clinical outcome or disease activity in AS. After the discovery of new pathological pathways, interleukins became targets. IL-6 was in the spotlight for some years; but, whereas some studies reported an association between IL-6 and disease activity<sup><a href="#ref-84">84</a><a href="#ref-86">86</a></sup>, others produced opposite results<sup><a href="#ref-87">87</a>,<a href="#ref-88">88</a></sup>.</p><p class="" id=d757e961>Calprotectin is a dimer of calcium-binding proteins used as a surrogate marker for gut inflammation. Its main application is monitoring disease activity in IBD<sup><a href="#ref-89">89</a></sup>. Both Crohns disease and ulcerative colitis are known to be associated with AS. The pathway is not clear; there are discrepancies concerning whether gut inflammation is the cause or the consequence of musculoskeletal disease. Given this, studies have tried to evaluate calprotectin for the management of AS. Duran <i>et al</i>.<sup><a href="#ref-90">90</a></sup> found that faecal calprotectin was associated with a higher disease activity and is a better predictor of bowel involvement than CRP, ESR, BASDAI, and Bath Ankylosing Spondylitis Functional Index (BASFI). Klingberg <i>et al</i>.<sup><a href="#ref-91">91</a></sup> confirmed these results and also suggested that calprotectin could be used to identify patients with AS at high risk of developing IBD. In accordance with this, another study<sup><a href="#ref-92">92</a></sup> demonstrated that exercise could decrease the levels of calprotectin in patients with AS and that this was associated with a reduction of disease activity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e990>Bone involvement</h2><p class="" id=d757e993>A typical feature of AS is bone formation co-existing with bone resorption. As with many other inflammatory diseases, there is an imbalance between these processes, which results in the appearance of syndesmophytes and bone erosions in patients with AS<sup><a href="#ref-93">93</a></sup>. IL-17, one of the most active cytokines in SpA, has a major role promoting osteoclastogenesis directly and through the activation of receptor activator of nuclear factor kappa B (RANK)<sup><a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. However, it does not exert its action alone; it works in combination with TNF-. The latter molecule triggers bone destruction through the RANK-RANK ligand (RANK-RANKL) system and inhibits bone formation via the overexpression of Dickkopf-related protein 1 (DKK1)<sup><a href="#ref-96">96</a></sup>, which suppresses the WNT bone pathway<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>. WNT/b-catenin signalling is a regulator of osteogenesis and its high levels promote the formation of osteoblasts and reduce osteoclastogenesis (and therefore bone resorption)<sup><a href="#ref-98">98</a></sup>. In contrast to TNF-, IL-17 has a dual effect because it can promote not only bone destruction by acting complementarily with TNF-<sup><a href="#ref-99">99</a></sup> but also bone formation at sites of inflammation or exposed to mechanical stress<sup><a href="#ref-100">100</a></sup>. An international study<sup><a href="#ref-101">101</a></sup> reported contradictory results, as they found that patients with AS had decreased indicators of osteoclast formation and bone resorption, suggesting a reduced capacity of osteoclast precursors to differentiate into osteoclasts and resorb, probably because of low RANKL/OPG and CD51/CD61 expression.</p><p class="" id=d757e1035>Ranganathan <i>et al</i>.<sup><a href="#ref-102">102</a></sup> found that macrophage migration inhibitory factor (MIF) was able to act on osteoblasts, promoting inflammation and new bone formation. They also suggested that the main source of MIF-producing cells was in the gut and that certain pathogens can induce its release. In addition, the level of MIF was predictive of progressive spinal damage.</p><p class="" id=d757e1045>More cytokines are being implicated in the pathogenesis of AS. El-Zayadi <i>et al</i>.<sup><a href="#ref-103">103</a></sup> recently reported that IL-22 regulates the function of mesenchymal cells, inducing proliferation, migration, and osteogenesis, in an inflammation-dependent context. IL-32 has been shown to be elevated in the joints and tissues of patients with AS and is able to induce osteoblast differentiation and atypical new bone formation<sup><a href="#ref-104">104</a></sup>. Another interleukin, IL-37, is also elevated in patients with osteoporosis in addition to AS, and its levels correlate with disease activity and bone mineral density<sup><a href="#ref-105">105</a></sup>. This is consistent with Kwon <i>et al</i>.<sup><a href="#ref-106">106</a></sup>, who found that osteoblast-lineage cells are increased in patients with AS and are reduced after therapy with infliximab. They also reported that the drug allows mature osteoblast differentiation in late inflammation.</p><p class="" id=d757e1071>Machado <i>et al</i>.<sup><a href="#ref-107">107</a></sup> stated that fat deposition in the vertebral corners is associated with radiographic progression, and they postulated that there should be a window of opportunity, as fat lesions can be preceded by inflammatory lesions. Interestingly, they also found that even though the absence of bone marrow oedema and fat deposition was negatively associated with radiographic progression, there was still bone formation in those areas, implying that there must be other pathways stimulating osteoproliferation.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e1084>Imaging</h2><p class="" id=d757e1087>The assessment of structural damage is valuable in patients with AS. The modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) (which consists of the sum of scores of the lumbar and cervical spine from a lateral view, ranging from 0 to 72) is a commonly used method for detecting changes in plain radiographs<sup><a href="#ref-108">108</a></sup>; however, X-rays are not a very sensitive tool and they are not able to properly differentiate squaring of vertebral bodies. Kim <i>et al</i>.<sup><a href="#ref-109">109</a></sup> evaluated the squaring of the first sacral vertebra (S1) by using a method proposed by Ralston <i>et al</i>.<sup><a href="#ref-110">110</a></sup>: squaring was associated with mSASSS and changes in magnetic resonance imaging (MRI) and therefore suggested that this assessment could be used to predict early axial involvement of the spine in AS. Regarding other predictors of progression, Dougados <i>et al</i>.<sup><a href="#ref-55">55</a></sup> found that HLA-B27-negative patients with normal CRP and normal MRI of the sacroiliac joints have a 1.2% likelihood of progressing to radiological axial SpA within 5 years. This likelihood of progression increased to 18.4% in HLA-B27-positive patients, with raised CRP and bone marrow oedema in the MRI of the sacroiliac joints. In HLA-B27-positive patients, smoking also seems to be associated with a proliferative metabolic pattern of the cartilage, which could justify its outgrowth and the development of enthesopathic lesions<sup><a href="#ref-111">111</a></sup>.</p><p class="" id=d757e1120>Althoff <i>et al</i>. were the first to suggest that contrast was not needed to assess axial activity in AS<sup><a href="#ref-112">112</a></sup>. However, Zhao <i>et al</i>.<sup><a href="#ref-113">113</a></sup> confirmed these results by using a large sample of patients, showing that the combination of short tau inversion recovery (STIR) and diffusion weighted imaging (DWI) in MRI is sufficient to monitor disease activity, avoiding the unnecessary use of contrast with its risks. Conversely, Bradbury <i>et al</i>.<sup><a href="#ref-114">114</a></sup> found that DWI has a moderate utility for assessing disease activity or monitoring response to treatment; however, it seems to be a great tool to distinguish axial SpA and non-inflammatory back pain.</p><p class="" id=d757e1145>Another MRI finding has been the discovery of the backfill sign. It was initially described by Weber <i>et al</i>.<sup><a href="#ref-115">115</a></sup>, who defined it as a high signal intensity filling the sacroiliac joint space on T1-weighted images which could represent fat metaplastic tissue filling excavations in subchondral bone; however, the histopathological origin has not been assessed yet. Recently, studies confirmed that the backfill sign had a high specificity for SpA (between 95.8% and 98%)<sup><a href="#ref-116">116</a></sup> but the sensitivity was only 59%<sup><a href="#ref-117">117</a></sup>. Therefore, its presence could be used to support the diagnosis of axial SpA, but its absence should not be used to exclude it.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d757e1166>Summary</h2><p class="" id=d757e1169>The numerous investigations and studies carried out within the last three years have improved the understanding of the pathogenesis of AS. This has facilitated the development of new treatment strategies with the consequent improvement of the quality life of patients with SpA. As more is known about the disease, the greater the complexity that is revealed, emphasising the need to continue investigation to achieve even more efficient control of the disease.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d757e1 class=n-a></a><h2 class=main-title id=d1114>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d757e1176 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d1493>References</h2><div class="section ref-list"><a name=d757e1176 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d757e1183 class=n-a></a>Chen B, Li J, He C, <i> et al.</i>: Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (Review). <i>Mol Med Rep.</i> 2017; <b>15</b>(4): 194351. <a target=xrefwindow id=d757e1194 href="http://www.ncbi.nlm.nih.gov/pubmed/28259985">PubMed Abstract </a> | <a target=xrefwindow id=d757e1197 href="http://dx.doi.org/10.3892/mmr.2017.6248">Publisher Full Text </a> | <a target=xrefwindow id=d757e1201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5364987">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d757e1210 class=n-a></a>Reveille JD: The genetic basis of ankylosing spondylitis. <i>Curr Opin Rheumatol.</i> 2006; <b>18</b>(4): 33241. <a target=xrefwindow id=d757e1218 href="http://www.ncbi.nlm.nih.gov/pubmed/16763451">PubMed Abstract </a> | <a target=xrefwindow id=d757e1221 href="http://dx.doi.org/10.1097/01.bor.0000231899.81677.04">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d757e1230 class=n-a></a>Rubin LA, Amos CI, Wade JA, <i> et al.</i>: Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. <i>Arthritis Rheum.</i> 1994; <b>37</b>(8): 121220. <a target=xrefwindow id=d757e1241 href="http://www.ncbi.nlm.nih.gov/pubmed/8053961">PubMed Abstract </a> | <a target=xrefwindow id=d757e1244 href="http://dx.doi.org/10.1002/art.1780370816">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d757e1253 class=n-a></a>Cortes A, Pulit SL, Leo PJ, <i> et al.</i>: Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with <i>ERAP1</i>. <i>Nat Commun.</i> 2015; <b>6</b>: 7146. <a target=xrefwindow id=d757e1267 href="http://www.ncbi.nlm.nih.gov/pubmed/25994336">PubMed Abstract </a> | <a target=xrefwindow id=d757e1271 href="http://dx.doi.org/10.1038/ncomms8146">Publisher Full Text </a> | <a target=xrefwindow id=d757e1274 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4443427">Free Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727532238"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1283 class=n-a></a>Ozen G, Deniz R, Eren F, <i> et al.</i>: Association of <i>ERAP1</i>, <i>IL23R</i> and <i>PTGER4</i> Polymorphisms with Radiographic Severity of Ankylosing Spondylitis. <i>Open Rheumatol J.</i> 2017; <b>11</b>: 19. <a target=xrefwindow id=d757e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/28400866">PubMed Abstract </a> | <a target=xrefwindow id=d757e1307 href="http://dx.doi.org/10.2174/1874312901711010001">Publisher Full Text </a> | <a target=xrefwindow id=d757e1310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5366379">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727532238">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733989675"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1324 class=n-a></a>Wang M, Xu S, Zhang X, <i> et al.</i>: Association of TLR7 gene copy number variations with ankylosing spondylitis in a Chinese population: a case control study. <i>Clin Exp Rheumatol.</i> 2018. <a target=xrefwindow id=d757e1332 href="http://www.ncbi.nlm.nih.gov/pubmed/29533758">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733989675">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733989676"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1345 class=n-a></a>Ruan WF, Xie JT, Jin Q, <i> et al.</i>: The Diagnostic and Prognostic Role of Interleukin 12B and Interleukin 6R Gene Polymorphism in Patients With Ankylosing Spondylitis. <i>J Clin Rheumatol.</i> 2018; <b>24</b>(1): 1824. <a target=xrefwindow id=d757e1356 href="http://www.ncbi.nlm.nih.gov/pubmed/29200018">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733989676">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d757e1369 class=n-a></a>Costello ME, Elewaut D, Kenna TJ, <i> et al.</i>: Microbes, the gut and ankylosing spondylitis. <i>Arthritis Res Ther.</i> 2013; <b>15</b>(3): 214. <a target=xrefwindow id=d757e1380 href="http://www.ncbi.nlm.nih.gov/pubmed/23750937">PubMed Abstract </a> | <a target=xrefwindow id=d757e1383 href="http://dx.doi.org/10.1186/ar4228">Publisher Full Text </a> | <a target=xrefwindow id=d757e1387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4060176">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d757e1396 class=n-a></a>Benjamin R, Parham P: HLA-B27 and disease: a consequence of inadvertent antigen presentation? <i>Rheum Dis Clin North Am.</i> 1992; <b>18</b>(1): 1121. <a target=xrefwindow id=d757e1404 href="http://www.ncbi.nlm.nih.gov/pubmed/1561398">PubMed Abstract </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d757e1413 class=n-a></a>Mear JP, Schreiber KL, Mnz C, <i> et al.</i>: Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. <i>J Immunol.</i> 1999; <b>163</b>(12): 666570. <a target=xrefwindow id=d757e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/10586062">PubMed Abstract </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d757e1433 class=n-a></a>Smith JA, Colbert RA: Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(2): 23141. <a target=xrefwindow id=d757e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/24504793">PubMed Abstract </a> | <a target=xrefwindow id=d757e1444 href="http://dx.doi.org/10.1002/art.38291">Publisher Full Text </a> | <a target=xrefwindow id=d757e1447 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4058712">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d757e1457 class=n-a></a>Schittenhelm RB, Sian TC, Wilmann PG, <i> et al.</i>: Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(3): 70213. <a target=xrefwindow id=d757e1468 href="http://www.ncbi.nlm.nih.gov/pubmed/25418920">PubMed Abstract </a> | <a target=xrefwindow id=d757e1471 href="http://dx.doi.org/10.1002/art.38963">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d757e1480 class=n-a></a>Allen RL, O'Callaghan CA, McMichael AJ, <i> et al.</i>: Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. <i>J Immunol.</i> 1999; <b>162</b>(9): 50458. <a target=xrefwindow id=d757e1491 href="http://www.ncbi.nlm.nih.gov/pubmed/10227970">PubMed Abstract </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d757e1500 class=n-a></a>Kollnberger S, Bird L, Sun MY, <i> et al.</i>: Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. <i>Arthritis Rheum.</i> 2002; <b>46</b>(11): 297282. <a target=xrefwindow id=d757e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/12428240">PubMed Abstract </a> | <a target=xrefwindow id=d757e1514 href="http://dx.doi.org/10.1002/art.10605">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d757e1523 class=n-a></a>Kollnberger S, Chan A, Sun MY, <i> et al.</i>: Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. <i>Eur J Immunol.</i> 2007; <b>37</b>(5): 131322. <a target=xrefwindow id=d757e1534 href="http://www.ncbi.nlm.nih.gov/pubmed/17407096">PubMed Abstract </a> | <a target=xrefwindow id=d757e1537 href="http://dx.doi.org/10.1002/eji.200635997">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d757e1546 class=n-a></a>Payeli SK, Kollnberger S, Marroquin Belaunzaran O, <i> et al.</i>: Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. <i>Arthritis Rheum.</i> 2012; <b>64</b>(10): 313949. <a target=xrefwindow id=d757e1557 href="http://www.ncbi.nlm.nih.gov/pubmed/22576154">PubMed Abstract </a> | <a target=xrefwindow id=d757e1560 href="http://dx.doi.org/10.1002/art.34538">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726256640"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1569 class=n-a></a>Ridley A, Hatano H, Wong-Baeza I, <i> et al.</i>: Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(4): 90114. <a target=xrefwindow id=d757e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/26841353">PubMed Abstract </a> | <a target=xrefwindow id=d757e1583 href="http://dx.doi.org/10.1002/art.39515">Publisher Full Text </a> | <a target=xrefwindow id=d757e1587 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4855641">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726256640">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d757e1601 class=n-a></a>Dong C: T<sub>H</sub>17 cells in development: an updated view of their molecular identity and genetic programming. <i>Nat Rev Immunol.</i> 2008; <b>8</b>(5): 33748. <a target=xrefwindow id=d757e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/18408735">PubMed Abstract </a> | <a target=xrefwindow id=d757e1615 href="http://dx.doi.org/10.1038/nri2295">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1032436"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1624 class=n-a></a>Yen D, Cheung J, Scheerens H, <i> et al.</i>: IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. <i>J Clin Invest.</i> 2006; <b>116</b>(5): 13106. <a target=xrefwindow id=d757e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/16670770">PubMed Abstract </a> | <a target=xrefwindow id=d757e1638 href="http://dx.doi.org/10.1172/JCI21404">Publisher Full Text </a> | <a target=xrefwindow id=d757e1642 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1451201">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1032436">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d757e1655 class=n-a></a>Oppmann B, Lesley R, Blom B, <i> et al.</i>: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. <i>Immunity.</i> 2000; <b>13</b>(5): 71525. <a target=xrefwindow id=d757e1666 href="http://www.ncbi.nlm.nih.gov/pubmed/11114383">PubMed Abstract </a> | <a target=xrefwindow id=d757e1669 href="http://dx.doi.org/10.1016/S1074-7613(00)00070-4">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726068208"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1678 class=n-a></a>Jain R, Chen Y, Kanno Y, <i> et al.</i>: Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells. <i>Immunity.</i> 2016; <b>44</b>(1): 13142. <a target=xrefwindow id=d757e1689 href="http://www.ncbi.nlm.nih.gov/pubmed/26750311">PubMed Abstract </a> | <a target=xrefwindow id=d757e1692 href="http://dx.doi.org/10.1016/j.immuni.2015.11.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726068208">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d757e1705 class=n-a></a>Ellinghaus D, Zhang H, Zeissig S, <i> et al.</i>: Association between variants of <i>PRDM1</i> and <i>NDP52</i> and Crohn's disease, based on exome sequencing and functional studies. <i>Gastroenterology.</i> 2013; <b>145</b>(2): 33947. <a target=xrefwindow id=d757e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/23624108">PubMed Abstract </a> | <a target=xrefwindow id=d757e1726 href="http://dx.doi.org/10.1053/j.gastro.2013.04.040">Publisher Full Text </a> | <a target=xrefwindow id=d757e1729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3753067">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5750956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1738 class=n-a></a>Ghoreschi K, Laurence A, Yang XP, <i> et al.</i>: Generation of pathogenic T<sub>H</sub>17 cells in the absence of TGF- signalling. <i>Nature.</i> 2010; <b>467</b>(7318): 96771. <a target=xrefwindow id=d757e1752 href="http://www.ncbi.nlm.nih.gov/pubmed/20962846">PubMed Abstract </a> | <a target=xrefwindow id=d757e1756 href="http://dx.doi.org/10.1038/nature09447">Publisher Full Text </a> | <a target=xrefwindow id=d757e1759 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3108066">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5750956">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725453504"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1773 class=n-a></a>Gagliani N, Amezcua Vesely MC, Iseppon A, <i> et al.</i>: Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. <i>Nature.</i> 2015; <b>523</b>(7559): 2215. <a target=xrefwindow id=d757e1784 href="http://www.ncbi.nlm.nih.gov/pubmed/25924064">PubMed Abstract </a> | <a target=xrefwindow id=d757e1787 href="http://dx.doi.org/10.1038/nature14452">Publisher Full Text </a> | <a target=xrefwindow id=d757e1791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4498984">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725453504">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d757e1804 class=n-a></a>Maxwell JR, Zhang Y, Brown WA, <i> et al.</i>: Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation. <i>Immunity.</i> 2015; <b>43</b>(4): 73950. <a target=xrefwindow id=d757e1815 href="http://www.ncbi.nlm.nih.gov/pubmed/26431947">PubMed Abstract </a> | <a target=xrefwindow id=d757e1818 href="http://dx.doi.org/10.1016/j.immuni.2015.08.019">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725624053"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1827 class=n-a></a>Ohnmacht C, Park JH, Cording S, <i> et al.</i>: MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORt<sup>+</sup> T cells. <i>Science.</i> 2015; <b>349</b>(6251): 98993. <a target=xrefwindow id=d757e1841 href="http://www.ncbi.nlm.nih.gov/pubmed/26160380">PubMed Abstract </a> | <a target=xrefwindow id=d757e1845 href="http://dx.doi.org/10.1126/science.aac4263">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725624053">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d757e1858 class=n-a></a>Fasching P, Stradner M, Graninger W, <i> et al.</i>: Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders. <i>Molecules.</i> 2017; <b>22</b>(1). pii: E134. <a target=xrefwindow id=d757e1869 href="http://www.ncbi.nlm.nih.gov/pubmed/28098832">PubMed Abstract </a> | <a target=xrefwindow id=d757e1872 href="http://dx.doi.org/10.3390/molecules22010134">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725500745"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e1881 class=n-a></a>Costello ME, Ciccia F, Willner D, <i> et al.</i>: Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(3): 68691. <a target=xrefwindow id=d757e1892 href="http://www.ncbi.nlm.nih.gov/pubmed/25417597">PubMed Abstract </a> | <a target=xrefwindow id=d757e1895 href="http://dx.doi.org/10.1002/art.38967">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725500745">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d757e1908 class=n-a></a>Ciccia F, Rizzo A, Triolo G: Subclinical gut inflammation in ankylosing spondylitis. <i>Curr Opin Rheumatol.</i> 2016; <b>28</b>(1): 8996. <a target=xrefwindow id=d757e1916 href="http://www.ncbi.nlm.nih.gov/pubmed/26599385">PubMed Abstract </a> | <a target=xrefwindow id=d757e1919 href="http://dx.doi.org/10.1097/BOR.0000000000000239">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d757e1929 class=n-a></a>Jacques P, Elewaut D, Mielants H: Interactions between gut inflammation and arthritis/spondylitis. <i>Curr Opin Rheumatol.</i> 2010; <b>22</b>(4): 36874. <a target=xrefwindow id=d757e1937 href="http://www.ncbi.nlm.nih.gov/pubmed/20485176">PubMed Abstract </a> | <a target=xrefwindow id=d757e1940 href="http://dx.doi.org/10.1097/BOR.0b013e3283393807">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d757e1949 class=n-a></a>Van Praet L, Van den Bosch FE, Jacques P, <i> et al.</i>: Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. <i>Ann Rheum Dis.</i> 2013; <b>72</b>(3): 4147. <a target=xrefwindow id=d757e1960 href="http://www.ncbi.nlm.nih.gov/pubmed/23139267">PubMed Abstract </a> | <a target=xrefwindow id=d757e1963 href="http://dx.doi.org/10.1136/annrheumdis-2012-202135">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d757e1972 class=n-a></a>Asquith M, Elewaut D, Lin P, <i> et al.</i>: The role of the gut and microbes in the pathogenesis of spondyloarthritis. <i>Best Pract Res Clin Rheumatol.</i> 2014; <b>28</b>(5): 687702. <a target=xrefwindow id=d757e1983 href="http://www.ncbi.nlm.nih.gov/pubmed/25488778">PubMed Abstract </a> | <a target=xrefwindow id=d757e1986 href="http://dx.doi.org/10.1016/j.berh.2014.10.018">Publisher Full Text </a> | <a target=xrefwindow id=d757e1990 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4293151">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d757e1999 class=n-a></a>Dalal SR, Chang EB: The microbial basis of inflammatory bowel diseases. <i>J Clin Invest.</i> 2014; <b>124</b>(10): 41906. <a target=xrefwindow id=d757e2007 href="http://www.ncbi.nlm.nih.gov/pubmed/25083986">PubMed Abstract </a> | <a target=xrefwindow id=d757e2010 href="http://dx.doi.org/10.1172/JCI72330">Publisher Full Text </a> | <a target=xrefwindow id=d757e2013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4191005">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d757e2022 class=n-a></a>Martnez-Gonzlez O, Cantero-Hinojosa J, Paule-Sastre P, <i> et al.</i>: Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives. <i>Br J Rheumatol.</i> 1994; <b>33</b>(7): 6447. <a target=xrefwindow id=d757e2033 href="http://www.ncbi.nlm.nih.gov/pubmed/8019793">PubMed Abstract </a> | <a target=xrefwindow id=d757e2036 href="http://dx.doi.org/10.1093/rheumatology/33.7.644">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d757e2045 class=n-a></a>Taurog JD, Richardson JA, Croft JT, <i> et al.</i>: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. <i>J Exp Med.</i> 1994; <b>180</b>(6): 235964. <a target=xrefwindow id=d757e2056 href="http://www.ncbi.nlm.nih.gov/pubmed/7964509">PubMed Abstract </a> | <a target=xrefwindow id=d757e2059 href="http://dx.doi.org/10.1084/jem.180.6.2359">Publisher Full Text </a> | <a target=xrefwindow id=d757e2063 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2191772">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d757e2073 class=n-a></a>Ebringer A: The relationship between <i>Klebsiella</i> infection and ankylosing spondylitis. <i>Baillieres Clin Rheumatol.</i> 1989; <b>3</b>(2): 32138. <a target=xrefwindow id=d757e2084 href="http://www.ncbi.nlm.nih.gov/pubmed/2670258">PubMed Abstract </a> | <a target=xrefwindow id=d757e2087 href="http://dx.doi.org/10.1016/S0950-3579(89)80024-X">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d757e2096 class=n-a></a>Rosenbaum JT, Asquith MJ: The Microbiome: a Revolution in Treatment for Rheumatic Diseases? <i>Curr Rheumatol Rep.</i> 2016; <b>18</b>(10): 62. <a target=xrefwindow id=d757e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/27641915">PubMed Abstract </a> | <a target=xrefwindow id=d757e2107 href="http://dx.doi.org/10.1007/s11926-016-0614-8">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d757e2116 class=n-a></a>Kang EH, Lee JT, Lee HJ, <i> et al.</i>: Chronic Periodontitis Is Associated With Spinal Dysmobility in Patients With Ankylosing Spondylitis. <i>J Periodontol.</i> 2015; <b>86</b>(12): 130313. <a target=xrefwindow id=d757e2127 href="http://www.ncbi.nlm.nih.gov/pubmed/26291296">PubMed Abstract </a> | <a target=xrefwindow id=d757e2130 href="http://dx.doi.org/10.1902/jop.2015.150202">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d757e2139 class=n-a></a>Bautista-Molano W, van der Heijde D, Landew R, <i> et al.</i>: Is there a relationship between spondyloarthritis and periodontitis? A case-control study. <i>RMD Open.</i> 2017; <b>3</b>(2): e000547. <a target=xrefwindow id=d757e2150 href="http://www.ncbi.nlm.nih.gov/pubmed/29299339">PubMed Abstract </a> | <a target=xrefwindow id=d757e2153 href="http://dx.doi.org/10.1136/rmdopen-2017-000547">Publisher Full Text </a> | <a target=xrefwindow id=d757e2157 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5729302">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727132779"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2166 class=n-a></a>Landi M, Maldonado-Ficco H, Perez-Alamino R, <i> et al.</i>: Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(51): e5652. <a target=xrefwindow id=d757e2177 href="http://www.ncbi.nlm.nih.gov/pubmed/28002334">PubMed Abstract </a> | <a target=xrefwindow id=d757e2180 href="http://dx.doi.org/10.1097/MD.0000000000005652">Publisher Full Text </a> | <a target=xrefwindow id=d757e2184 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5181818">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727132779">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d757e2197 class=n-a></a>Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE: Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky. <i>Curr Rheumatol Rep.</i> 2018; <b>20</b>(6): 35. <a target=xrefwindow id=d757e2205 href="http://www.ncbi.nlm.nih.gov/pubmed/29754330">PubMed Abstract </a> | <a target=xrefwindow id=d757e2208 href="http://dx.doi.org/10.1007/s11926-018-0744-2">Publisher Full Text </a> | <a target=xrefwindow id=d757e2211 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5949138">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725799477"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2221 class=n-a></a>Webers C, Essers I, Ramiro S, <i> et al.</i>: Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. <i>Rheumatology (Oxford).</i> 2016; <b>55</b>(3): 41928. <a target=xrefwindow id=d757e2232 href="http://www.ncbi.nlm.nih.gov/pubmed/26385369">PubMed Abstract </a> | <a target=xrefwindow id=d757e2235 href="http://dx.doi.org/10.1093/rheumatology/kev340">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725799477">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d757e2248 class=n-a></a>Park W, Yoo DH, Jaworski J, <i> et al.</i>: Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study. <i>Arthritis Res Ther.</i> 2016; <b>18</b>: 25. <a target=xrefwindow id=d757e2259 href="http://www.ncbi.nlm.nih.gov/pubmed/26795209">PubMed Abstract </a> | <a target=xrefwindow id=d757e2262 href="http://dx.doi.org/10.1186/s13075-016-0930-4">Publisher Full Text </a> | <a target=xrefwindow id=d757e2266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4721187">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d757e2275 class=n-a></a>Emery P, Vencovsk J, Sylwestrzak A, <i> et al.</i>: 52-week results of the phase 3 randomized study comparing SB4 with reference etanercept in patients with active rheumatoid arthritis. <i>Rheumatology (Oxford).</i> 2017; <b>56</b>(12): 2093101. <a target=xrefwindow id=d757e2286 href="http://www.ncbi.nlm.nih.gov/pubmed/28968793">PubMed Abstract </a> | <a target=xrefwindow id=d757e2289 href="http://dx.doi.org/10.1093/rheumatology/kex269">Publisher Full Text </a> | <a target=xrefwindow id=d757e2293 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5850652">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d757e2302 class=n-a></a>Braun J, Baraliakos X, Deodhar A, <i> et al.</i>: Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(6): 10707. <a target=xrefwindow id=d757e2313 href="http://www.ncbi.nlm.nih.gov/pubmed/27965257">PubMed Abstract </a> | <a target=xrefwindow id=d757e2316 href="http://dx.doi.org/10.1136/annrheumdis-2016-209730">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d757e2325 class=n-a></a><a target=xrefwindow id=d757e2326 href="https://clinicaltrials.gov/ct2/show/NCT02696785">https://clinicaltrials.gov/ct2/show/NCT02696785</a>. </span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d757e2336 class=n-a></a><a target=xrefwindow id=d757e2337 href="https://clinicaltrials.gov/ct2/show/study/NCT02429882">https://clinicaltrials.gov/ct2/show/study/NCT02429882</a>. </span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d757e2348 class=n-a></a><a target=xrefwindow id=d757e2349 href="https://clinicaltrials.gov/ct2/show/NCT02438787">https://clinicaltrials.gov/ct2/show/NCT02438787</a>. </span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d757e2359 class=n-a></a><a target=xrefwindow id=d757e2360 href="https://clinicaltrials.gov/ct2/show/NCT02437162">https://clinicaltrials.gov/ct2/show/NCT02437162</a>. </span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d757e2370 class=n-a></a>Genovese MC, Weinblatt ME, Mease PJ, <i> et al.</i>: Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis. <i>Rheumatology (Oxford).</i> 2018. <a target=xrefwindow id=d757e2378 href="http://www.ncbi.nlm.nih.gov/pubmed/30032191">PubMed Abstract </a> | <a target=xrefwindow id=d757e2381 href="http://dx.doi.org/10.1093/rheumatology/key173">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d757e2390 class=n-a></a><a target=xrefwindow id=d757e2391 href="https://clinicaltrials.gov/ct2/show/NCT02243787">https://clinicaltrials.gov/ct2/show/NCT02243787</a>. </span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d757e2401 class=n-a></a>Hammitzsch A, Tallant C, Fedorov O, <i> et al.</i>: CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(34): 1076873. <a target=xrefwindow id=d757e2412 href="http://www.ncbi.nlm.nih.gov/pubmed/26261308">PubMed Abstract </a> | <a target=xrefwindow id=d757e2415 href="http://dx.doi.org/10.1073/pnas.1501956112">Publisher Full Text </a> | <a target=xrefwindow id=d757e2419 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4553799">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d757e2428 class=n-a></a>Sieper J, Braun J, Kay J, <i> et al.</i>: Sarilumab for the treatment of ankylosing spondylitis: Results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN). <i>Ann Rheum Dis.</i> 2015; <b>74</b>(6): 10517. <a target=xrefwindow id=d757e2439 href="http://www.ncbi.nlm.nih.gov/pubmed/24550171">PubMed Abstract </a> | <a target=xrefwindow id=d757e2442 href="http://dx.doi.org/10.1136/annrheumdis-2013-204963">Publisher Full Text </a> | <a target=xrefwindow id=d757e2446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4431338">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d757e2456 class=n-a></a>van der Heijde D, Deodhar A, Wei JC, <i> et al.</i>: Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(8): 13407. <a target=xrefwindow id=d757e2467 href="http://www.ncbi.nlm.nih.gov/pubmed/28130206">PubMed Abstract </a> | <a target=xrefwindow id=d757e2470 href="http://dx.doi.org/10.1136/annrheumdis-2016-210322">Publisher Full Text </a> | <a target=xrefwindow id=d757e2474 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5738601">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d757e2483 class=n-a></a>Dougados M, Sepriano A, Molto A, <i> et al.</i>: Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(11): 18238. <a target=xrefwindow id=d757e2494 href="http://www.ncbi.nlm.nih.gov/pubmed/28684556">PubMed Abstract </a> | <a target=xrefwindow id=d757e2497 href="http://dx.doi.org/10.1136/annrheumdis-2017-211596">Publisher Full Text </a> | <a target=xrefwindow id=d757e2501 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5705846">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d757e2510 class=n-a></a>Cho IH, Lee N, Song D, <i> et al.</i>: Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept. <i>MAbs.</i> 2016; <b>8</b>(6): 113655. <a target=xrefwindow id=d757e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/27246928">PubMed Abstract </a> | <a target=xrefwindow id=d757e2524 href="http://dx.doi.org/10.1080/19420862.2016.1193659">Publisher Full Text </a> | <a target=xrefwindow id=d757e2528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4968139">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d757e2537 class=n-a></a>Park W, Hrycaj P, Jeka S, <i> et al.</i>: A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. <i>Ann Rheum Dis.</i> 2013; <b>72</b>(10): 160512. <a target=xrefwindow id=d757e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/23687259">PubMed Abstract </a> | <a target=xrefwindow id=d757e2551 href="http://dx.doi.org/10.1136/annrheumdis-2012-203091">Publisher Full Text </a> | <a target=xrefwindow id=d757e2555 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3786643">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d757e2564 class=n-a></a>Park W, Yoo DH, Miranda P, <i> et al.</i>: Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(2): 34654. <a target=xrefwindow id=d757e2575 href="http://www.ncbi.nlm.nih.gov/pubmed/27117698">PubMed Abstract </a> | <a target=xrefwindow id=d757e2578 href="http://dx.doi.org/10.1136/annrheumdis-2015-208783">Publisher Full Text </a> | <a target=xrefwindow id=d757e2582 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5284340">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d757e2591 class=n-a></a>Yoo DH, Racewicz A, Brzezicki J, <i> et al.</i>: A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study. <i>Arthritis Res Ther.</i> 2016; <b>18</b>: 82. <a target=xrefwindow id=d757e2602 href="http://www.ncbi.nlm.nih.gov/pubmed/27038608">PubMed Abstract </a> | <a target=xrefwindow id=d757e2605 href="http://dx.doi.org/10.1186/s13075-016-0981-6">Publisher Full Text </a> | <a target=xrefwindow id=d757e2609 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4818886">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d757e2619 class=n-a></a>Yoo DH, Prodanovic N, Jaworski J, <i> et al.</i>: Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(2): 35563. <a target=xrefwindow id=d757e2630 href="http://www.ncbi.nlm.nih.gov/pubmed/27130908">PubMed Abstract </a> | <a target=xrefwindow id=d757e2633 href="http://dx.doi.org/10.1136/annrheumdis-2015-208786">Publisher Full Text </a> | <a target=xrefwindow id=d757e2637 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5284338">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d757e2646 class=n-a></a>Emery P, Vencovsk J, Sylwestrzak A, <i> et al.</i>: Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4. <i>Ann Rheum Dis.</i> 2017; pii: annrheumdis-2017-211591. <a target=xrefwindow id=d757e2654 href="http://www.ncbi.nlm.nih.gov/pubmed/28794078">PubMed Abstract </a> | <a target=xrefwindow id=d757e2657 href="http://dx.doi.org/10.1136/annrheumdis-2017-211591">Publisher Full Text </a> | <a target=xrefwindow id=d757e2660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5705842">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d757e2669 class=n-a></a><a target=xrefwindow id=d757e2670><a target=xrefwindow id=d757e2670 href="https://clinicaltrials.gov/ct2/show/NCT03100734simple"> https://clinicaltrials.gov/ct2/show/NCT03100734</a></a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d757e2679 class=n-a></a>Liu W, Wu YH, Zhang L, <i> et al.</i>: Elevated serum levels of IL-6 and IL-17 may associate with the development of ankylosing spondylitis. <i>Int J Clin Exp Med.</i> 2015; <b>8</b>(10): 1736276. <a target=xrefwindow id=d757e2690 href="http://www.ncbi.nlm.nih.gov/pubmed/26770328">PubMed Abstract </a> | <a target=xrefwindow id=d757e2693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4694228">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d757e2702 class=n-a></a>Yago T, Nanke Y, Kawamoto M, <i> et al.</i>: IL-23 and Th17 Disease in Inflammatory Arthritis. <i>J Clin Med.</i> 2017; <b>6</b>(9): pii: E81. <a target=xrefwindow id=d757e2713 href="http://www.ncbi.nlm.nih.gov/pubmed/28850053">PubMed Abstract </a> | <a target=xrefwindow id=d757e2716 href="http://dx.doi.org/10.3390/jcm6090081">Publisher Full Text </a> | <a target=xrefwindow id=d757e2720 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5615274">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727624476"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2729 class=n-a></a>Baraliakos X, Kivitz AJ, Deodhar AA, <i> et al.</i>: Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. <i>Clin Exp Rheumatol.</i> 2018; <b>36</b>(1): 505. <a target=xrefwindow id=d757e2740 href="http://www.ncbi.nlm.nih.gov/pubmed/28516874">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727624476">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727343690"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2754 class=n-a></a>Marzo-Ortega H, Sieper J, Kivitz A, <i> et al.</i>: Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study. <i>Arthritis Care Res (Hoboken).</i> 2017; <b>69</b>(7): 10209. <a target=xrefwindow id=d757e2765 href="http://www.ncbi.nlm.nih.gov/pubmed/28235249">PubMed Abstract </a> | <a target=xrefwindow id=d757e2768 href="http://dx.doi.org/10.1002/acr.23233">Publisher Full Text </a> | <a target=xrefwindow id=d757e2772 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5518281">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727343690">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732345838"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2785 class=n-a></a>Pavelka K, Kivitz A, Dokoupilova E, <i> et al.</i>: Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3. <i>Arthritis Res Ther.</i> 2017; <b>19</b>(1): 285. <a target=xrefwindow id=d757e2796 href="http://www.ncbi.nlm.nih.gov/pubmed/29273067">PubMed Abstract </a> | <a target=xrefwindow id=d757e2799 href="http://dx.doi.org/10.1186/s13075-017-1490-y">Publisher Full Text </a> | <a target=xrefwindow id=d757e2803 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5741872">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732345838">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d757e2816 class=n-a></a><a target=xrefwindow id=d757e2817 href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005021-39/CZ">https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005021-39/CZ</a>. </span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d757e2827 class=n-a></a><a target=xrefwindow id=d757e2828 href="https://clinicaltrials.gov/ct2/show/study/NCT02696798">https://clinicaltrials.gov/ct2/show/study/NCT02696798</a>. </span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717948705"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2838 class=n-a></a>Sherlock JP, Joyce-Shaikh B, Turner SP, <i> et al.</i>: IL-23 induces spondyloarthropathy by acting on ROR-t<sup>+</sup> CD3<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> entheseal resident T cells. <i>Nat Med.</i> 2012; <b>18</b>(7): 106976. <a target=xrefwindow id=d757e2862 href="http://www.ncbi.nlm.nih.gov/pubmed/22772566">PubMed Abstract </a> | <a target=xrefwindow id=d757e2865 href="http://dx.doi.org/10.1038/nm.2817">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717948705">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718020573"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2878 class=n-a></a>McInnes IB, Kavanaugh A, Gottlieb AB, <i> et al.</i>: Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. <i>Lancet.</i> 2013; <b>382</b>(9894): 7809. <a target=xrefwindow id=d757e2889 href="http://www.ncbi.nlm.nih.gov/pubmed/23769296">PubMed Abstract </a> | <a target=xrefwindow id=d757e2892 href="http://dx.doi.org/10.1016/S0140-6736(13)60594-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718020573">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718228216"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2906 class=n-a></a>Poddubnyy D, Hermann KG, Callhoff J, <i> et al.</i>: Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS). <i>Ann Rheum Dis.</i> 2014; <b>73</b>(5): 81723. <a target=xrefwindow id=d757e2917 href="http://www.ncbi.nlm.nih.gov/pubmed/24389297">PubMed Abstract </a> | <a target=xrefwindow id=d757e2920 href="http://dx.doi.org/10.1136/annrheumdis-2013-204248">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718228216">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731259662"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2933 class=n-a></a>Fleischmann RM, Wagner F, Kivitz AJ, <i> et al.</i>: Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(12): 228391. <a target=xrefwindow id=d757e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/28941216">PubMed Abstract </a> | <a target=xrefwindow id=d757e2947 href="http://dx.doi.org/10.1002/art.40319">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731259662">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d757e2960 class=n-a></a>Silacci M, Lembke W, Woods R, <i> et al.</i>: Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. <i>MAbs.</i> 2016; <b>8</b>(1): 1419. <a target=xrefwindow id=d757e2971 href="http://www.ncbi.nlm.nih.gov/pubmed/26390837">PubMed Abstract </a> | <a target=xrefwindow id=d757e2974 href="http://dx.doi.org/10.1080/19420862.2015.1093266">Publisher Full Text </a> | <a target=xrefwindow id=d757e2978 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4966518">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727206345"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e2987 class=n-a></a>van der Heijde D, Ramiro S, Landew R, <i> et al.</i>: 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(6): 97891. <a target=xrefwindow id=d757e2998 href="http://www.ncbi.nlm.nih.gov/pubmed/28087505">PubMed Abstract </a> | <a target=xrefwindow id=d757e3001 href="http://dx.doi.org/10.1136/annrheumdis-2016-210770">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727206345">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718547847"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3014 class=n-a></a>Zvada J, Uher M, Sisol K, <i> et al.</i>: A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(1): 96102. <a target=xrefwindow id=d757e3025 href="http://www.ncbi.nlm.nih.gov/pubmed/25165033">PubMed Abstract </a> | <a target=xrefwindow id=d757e3028 href="http://dx.doi.org/10.1136/annrheumdis-2014-205202">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718547847">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d757e3041 class=n-a></a>Plasencia C, Kneepkens EL, Wolbink G, <i> et al.</i>: Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. <i>J Rheumatol.</i> 2015; <b>42</b>(9): 163846. <a target=xrefwindow id=d757e3052 href="http://www.ncbi.nlm.nih.gov/pubmed/26178279">PubMed Abstract </a> | <a target=xrefwindow id=d757e3055 href="http://dx.doi.org/10.3899/jrheum.141128">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727151497"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3065 class=n-a></a>Park JW, Kwon HM, Park JK, <i> et al.</i>: Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis. <i>PLoS One.</i> 2016; <b>11</b>(12): e0168958. <a target=xrefwindow id=d757e3076 href="http://www.ncbi.nlm.nih.gov/pubmed/28033420">PubMed Abstract </a> | <a target=xrefwindow id=d757e3079 href="http://dx.doi.org/10.1371/journal.pone.0168958">Publisher Full Text </a> | <a target=xrefwindow id=d757e3083 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5199008">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727151497">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732266870"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3096 class=n-a></a>Fattahi MJ, Jamshidi AR, Mahmoudi M, <i> et al.</i>: Evaluation of the efficacy and safety of -d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial. <i>Int Immunopharmacol.</i> 2018; <b>54</b>: 1127. <a target=xrefwindow id=d757e3107 href="http://www.ncbi.nlm.nih.gov/pubmed/29127910">PubMed Abstract </a> | <a target=xrefwindow id=d757e3110 href="http://dx.doi.org/10.1016/j.intimp.2017.11.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732266870">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718524879"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3123 class=n-a></a>Wanders A, Heijde Dv, Landew R, <i> et al.</i>: Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. <i>Arthritis Rheum.</i> 2005; <b>52</b>(6): 175665. <a target=xrefwindow id=d757e3134 href="http://www.ncbi.nlm.nih.gov/pubmed/15934081">PubMed Abstract </a> | <a target=xrefwindow id=d757e3137 href="http://dx.doi.org/10.1002/art.21054">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718524879">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725699115"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3150 class=n-a></a>Sieper J, Listing J, Poddubnyy D, <i> et al.</i>: Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS). <i>Ann Rheum Dis.</i> 2016; <b>75</b>(8): 143843. <a target=xrefwindow id=d757e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/26242443">PubMed Abstract </a> | <a target=xrefwindow id=d757e3164 href="http://dx.doi.org/10.1136/annrheumdis-2015-207897">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725699115">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d757e3177 class=n-a></a>Spoorenberg A, van der Heijde D, de Klerk E, <i> et al.</i>: Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. <i>J Rheumatol.</i> 1999; <b>26</b>(4): 9804. <a target=xrefwindow id=d757e3188 href="http://www.ncbi.nlm.nih.gov/pubmed/10229432">PubMed Abstract </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d757e3197 class=n-a></a>Wallis D, Haroon N, Ayearst R, <i> et al.</i>: Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? <i>J Rheumatol.</i> 2013; <b>40</b>(12): 203841. <a target=xrefwindow id=d757e3208 href="http://www.ncbi.nlm.nih.gov/pubmed/24187102">PubMed Abstract </a> | <a target=xrefwindow id=d757e3211 href="http://dx.doi.org/10.3899/jrheum.130588">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d757e3221 class=n-a></a>Gratacs J, Collado A, Filella X, <i> et al.</i>: Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. <i>Br J Rheumatol.</i> 1994; <b>33</b>(10): 92731. <a target=xrefwindow id=d757e3232 href="http://www.ncbi.nlm.nih.gov/pubmed/7921752">PubMed Abstract </a> | <a target=xrefwindow id=d757e3235 href="http://dx.doi.org/10.1093/rheumatology/33.10.927">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d757e3244 class=n-a></a>Bal A, Unlu E, Bahar G, <i> et al.</i>: Comparison of serum IL-1 beta, sIL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. <i>Clin Rheumatol.</i> 2007; <b>26</b>(2): 2115. <a target=xrefwindow id=d757e3255 href="http://www.ncbi.nlm.nih.gov/pubmed/16583185">PubMed Abstract </a> | <a target=xrefwindow id=d757e3258 href="http://dx.doi.org/10.1007/s10067-006-0283-5">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d757e3267 class=n-a></a>Romero-Sanchez C, Jaimes DA, Londoo J, <i> et al.</i>: Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis. <i>Clin Exp Rheumatol.</i> 2011; <b>29</b>(5): 82834. <a target=xrefwindow id=d757e3278 href="http://www.ncbi.nlm.nih.gov/pubmed/22041179">PubMed Abstract </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d757e3287 class=n-a></a>Pedersen SJ, Srensen IJ, Garnero P, <i> et al.</i>: ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF inhibitors. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(8): 137581. <a target=xrefwindow id=d757e3298 href="http://www.ncbi.nlm.nih.gov/pubmed/21551511">PubMed Abstract </a> | <a target=xrefwindow id=d757e3301 href="http://dx.doi.org/10.1136/ard.2010.138883">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d757e3310 class=n-a></a>Sveaas SH, Berg IJ, Provan SA, <i> et al.</i>: Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. <i>Scand J Rheumatol.</i> 2015; <b>44</b>(2): 11824. <a target=xrefwindow id=d757e3321 href="http://www.ncbi.nlm.nih.gov/pubmed/25756521">PubMed Abstract </a> | <a target=xrefwindow id=d757e3324 href="http://dx.doi.org/10.3109/03009742.2014.956142">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d757e3333 class=n-a></a>Lee YW, Lee KM, Lee JM, <i> et al.</i>: The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. <i>Korean J Intern Med.</i> 2018. <a target=xrefwindow id=d757e3341 href="http://www.ncbi.nlm.nih.gov/pubmed/29347813">PubMed Abstract </a> | <a target=xrefwindow id=d757e3344 href="http://dx.doi.org/10.3904/kjim.2016.324">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733990091"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3354 class=n-a></a>Duran A, Kobak S, Sen N, <i> et al.</i>: Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis. <i>Bosn J Basic Med Sci.</i> 2016; <b>16</b>(1): 714. <a target=xrefwindow id=d757e3365 href="http://www.ncbi.nlm.nih.gov/pubmed/26773186">PubMed Abstract </a> | <a target=xrefwindow id=d757e3368 href="http://dx.doi.org/10.17305/bjbms.2016.752">Publisher Full Text </a> | <a target=xrefwindow id=d757e3372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4765943">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733990091">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726390630"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3385 class=n-a></a>Klingberg E, Olerd G, Hammarsten O, <i> et al.</i>: The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study. <i>Osteoporos Int.</i> 2016; <b>27</b>(6): 202733. <a target=xrefwindow id=d757e3396 href="http://www.ncbi.nlm.nih.gov/pubmed/26809190">PubMed Abstract </a> | <a target=xrefwindow id=d757e3399 href="http://dx.doi.org/10.1007/s00198-016-3489-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726390630">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727027072"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3412 class=n-a></a>Levitova A, Hulejova H, Spiritovic M, <i> et al.</i>: Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis. <i>Arthritis Res Ther.</i> 2016; <b>18</b>(1): 275. <a target=xrefwindow id=d757e3423 href="http://www.ncbi.nlm.nih.gov/pubmed/27887637">PubMed Abstract </a> | <a target=xrefwindow id=d757e3426 href="http://dx.doi.org/10.1186/s13075-016-1180-1">Publisher Full Text </a> | <a target=xrefwindow id=d757e3430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5124318">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727027072">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d757e3443 class=n-a></a>Rossini M, Viapiana O, Adami S, <i> et al.</i>: Focal bone involvement in inflammatory arthritis: the role of IL17. <i>Rheumatol Int.</i> 2016; <b>36</b>(4): 46982. <a target=xrefwindow id=d757e3454 href="http://www.ncbi.nlm.nih.gov/pubmed/26521079">PubMed Abstract </a> | <a target=xrefwindow id=d757e3457 href="http://dx.doi.org/10.1007/s00296-015-3387-x">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d757e3466 class=n-a></a>Chabaud M, Miossec P: The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an <i>ex vivo</i> model. <i>Arthritis Rheum.</i> 2001; <b>44</b>(6): 1293303. <a target=xrefwindow id=d757e3477 href="http://www.ncbi.nlm.nih.gov/pubmed/11407688">PubMed Abstract </a> | <a target="xrefwindow" id="d757e3480" href="http://dx.doi.org/10.1002/1529-0131(200106)44:6<1293::AID-ART221&gt;3.0.CO;2-T">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d757e3489 class=n-a></a>Lubberts E, Joosten LA, Oppers B, <i> et al.</i>: IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. <i>J Immunol.</i> 2001; <b>167</b>(2): 100413. <a target=xrefwindow id=d757e3500 href="http://www.ncbi.nlm.nih.gov/pubmed/11441109">PubMed Abstract </a> | <a target=xrefwindow id=d757e3503 href="http://dx.doi.org/10.4049/jimmunol.167.2.1004">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1069825"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3513 class=n-a></a>Sato K, Suematsu A, Okamoto K, <i> et al.</i>: Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. <i>J Exp Med.</i> 2006; <b>203</b>(12): 267382. <a target=xrefwindow id=d757e3524 href="http://www.ncbi.nlm.nih.gov/pubmed/17088434">PubMed Abstract </a> | <a target=xrefwindow id=d757e3527 href="http://dx.doi.org/10.1084/jem.20061775">Publisher Full Text </a> | <a target=xrefwindow id=d757e3531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2118166">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1069825">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d757e3544 class=n-a></a>Baron R, Rawadi G: Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. <i>Endocrinology.</i> 2007; <b>148</b>(6): 263543. <a target=xrefwindow id=d757e3552 href="http://www.ncbi.nlm.nih.gov/pubmed/17395698">PubMed Abstract </a> | <a target=xrefwindow id=d757e3555 href="http://dx.doi.org/10.1210/en.2007-0270">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d757e3564 class=n-a></a>Glass DA 2nd, Bialek P, Ahn JD, <i> et al.</i>: Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. <i>Dev Cell.</i> 2005; <b>8</b>(5): 75164. <a target=xrefwindow id=d757e3575 href="http://www.ncbi.nlm.nih.gov/pubmed/15866165">PubMed Abstract </a> | <a target=xrefwindow id=d757e3578 href="http://dx.doi.org/10.1016/j.devcel.2005.02.017">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d757e3587 class=n-a></a>Osta B, Lavocat F, Eljaafari A, <i> et al.</i>: Effects of Interleukin-17A on Osteogenic Differentiation of Isolated Human Mesenchymal Stem Cells. <i>Front Immunol.</i> 2014; <b>5</b>: 425. <a target=xrefwindow id=d757e3598 href="http://www.ncbi.nlm.nih.gov/pubmed/25228904">PubMed Abstract </a> | <a target=xrefwindow id=d757e3601 href="http://dx.doi.org/10.3389/fimmu.2014.00425">Publisher Full Text </a> | <a target=xrefwindow id=d757e3605 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4151036">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d757e3614 class=n-a></a>Zhang F, Wang CL, Koyama Y, <i> et al.</i>: Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells. <i>Connect Tissue Res.</i> 2010; <b>51</b>(5): 35969. <a target=xrefwindow id=d757e3625 href="http://www.ncbi.nlm.nih.gov/pubmed/20497006">PubMed Abstract </a> | <a target=xrefwindow id=d757e3628 href="http://dx.doi.org/10.3109/03008200903456942">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730172674"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3637 class=n-a></a>Perptuo IP, Caetano-Lopes J, Vieira-Sousa E, <i> et al.</i>: Ankylosing Spondylitis Patients Have Impaired Osteoclast Gene Expression in Circulating Osteoclast Precursors. <i>Front Med (Lausanne).</i> 2017; <b>4</b>: 5. <a target=xrefwindow id=d757e3648 href="http://www.ncbi.nlm.nih.gov/pubmed/28191455">PubMed Abstract </a> | <a target=xrefwindow id=d757e3651 href="http://dx.doi.org/10.3389/fmed.2017.00005">Publisher Full Text </a> | <a target=xrefwindow id=d757e3655 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5269449">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730172674">F1000 Recommendation</a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727697627"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3669 class=n-a></a>Ranganathan V, Ciccia F, Zeng F, <i> et al.</i>: Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(9): 1796806. <a target=xrefwindow id=d757e3680 href="http://www.ncbi.nlm.nih.gov/pubmed/28597514">PubMed Abstract </a> | <a target=xrefwindow id=d757e3683 href="http://dx.doi.org/10.1002/art.40175">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727697627">F1000 Recommendation</a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727098049"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3696 class=n-a></a>El-Zayadi AA, Jones EA, Churchman SM, <i> et al.</i>: Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. <i>Rheumatology (Oxford).</i> 2017; <b>56</b>(3): 48893. <a target=xrefwindow id=d757e3707 href="http://www.ncbi.nlm.nih.gov/pubmed/27940584">PubMed Abstract </a> | <a target=xrefwindow id=d757e3710 href="http://dx.doi.org/10.1093/rheumatology/kew384">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727098049">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d757e3723 class=n-a></a>Lee EJ, Lee EJ, Chung YH, <i> et al.</i>: High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation. <i>Arthritis Res Ther.</i> 2015; <b>17</b>: 350. <a target=xrefwindow id=d757e3734 href="http://www.ncbi.nlm.nih.gov/pubmed/26634249">PubMed Abstract </a> | <a target=xrefwindow id=d757e3737 href="http://dx.doi.org/10.1186/s13075-015-0870-4">Publisher Full Text </a> | <a target=xrefwindow id=d757e3741 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4669668">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733990130"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3750 class=n-a></a>Fawzy RM, Ganeb SS, Said EA, <i> et al.</i>: Serum Level of Interleukin-37 and Expression of Its mRNA in Ankylosing Spondylitis Patients: Possible Role in Osteoporosis. <i>Egypt J Immunol.</i> 2016; <b>23</b>(1): 1929. <a target=xrefwindow id=d757e3761 href="http://www.ncbi.nlm.nih.gov/pubmed/28502149">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733990130">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727476252"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3774 class=n-a></a>Kwon SR, Jung KH, Lim MJ, <i> et al.</i>: The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis. <i>Clin Exp Rheumatol.</i> 2017; <b>35</b>(5): 83743. <a target=xrefwindow id=d757e3785 href="http://www.ncbi.nlm.nih.gov/pubmed/28375831">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727476252">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725851255"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3798 class=n-a></a>Machado PM, Baraliakos X, van der Heijde D, <i> et al.</i>: MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. <i>Ann Rheum Dis.</i> 2016; <b>75</b>(8): 148693. <a target=xrefwindow id=d757e3809 href="http://www.ncbi.nlm.nih.gov/pubmed/26462728">PubMed Abstract </a> | <a target=xrefwindow id=d757e3812 href="http://dx.doi.org/10.1136/annrheumdis-2015-208011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725851255">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d757e3826 class=n-a></a>Wanders AJ, Landew RB, Spoorenberg A, <i> et al.</i>: What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. <i>Arthritis Rheum.</i> 2004; <b>50</b>(8): 262232. <a target=xrefwindow id=d757e3837 href="http://www.ncbi.nlm.nih.gov/pubmed/15334477">PubMed Abstract </a> | <a target=xrefwindow id=d757e3840 href="http://dx.doi.org/10.1002/art.20446">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733990132"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3849 class=n-a></a>Kim JY, Lee S, Joo KB, <i> et al.</i>: Loss of anterior concavity of the first sacrum can predict spinal involvement in ankylosing spondylitis. <i>Rheumatol Int.</i> 2016; <b>36</b>(1): 1615. <a target=xrefwindow id=d757e3860 href="http://www.ncbi.nlm.nih.gov/pubmed/26387092">PubMed Abstract </a> | <a target=xrefwindow id=d757e3863 href="http://dx.doi.org/10.1007/s00296-015-3359-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733990132">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d757e3876 class=n-a></a>Ralston SH, Urquhart GD, Brzeski M, <i> et al.</i>: A new method for the radiological assessment of vertebral squaring in ankylosing spondylitis. <i>Ann Rheum Dis.</i> 1992; <b>51</b>(3): 3303. <a target=xrefwindow id=d757e3887 href="http://www.ncbi.nlm.nih.gov/pubmed/1575575">PubMed Abstract </a> | <a target=xrefwindow id=d757e3890 href="http://dx.doi.org/10.1136/ard.51.3.330">Publisher Full Text </a> | <a target=xrefwindow id=d757e3894 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1004654">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725977473"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3903 class=n-a></a>Munk HL, Gudmann NS, Christensen AF, <i> et al.</i>: Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B<sub>27</sub>. <i>Rheumatol Int.</i> 2016; <b>36</b>(4): 5419. <a target=xrefwindow id=d757e3917 href="http://www.ncbi.nlm.nih.gov/pubmed/26620690">PubMed Abstract </a> | <a target=xrefwindow id=d757e3921 href="http://dx.doi.org/10.1007/s00296-015-3397-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725977473">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d757e3934 class=n-a></a>Althoff CE, Feist E, Burova E, <i> et al.</i>: Magnetic resonance imaging of active sacroiliitis: do we really need gadolinium? <i>Eur J Radiol.</i> 2009; <b>71</b>(2): 2326. <a target=xrefwindow id=d757e3945 href="http://www.ncbi.nlm.nih.gov/pubmed/19446974">PubMed Abstract </a> | <a target=xrefwindow id=d757e3948 href="http://dx.doi.org/10.1016/j.ejrad.2009.04.034">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727629211"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e3957 class=n-a></a>Zhao YH, Cao YY, Zhang Q, <i> et al.</i>: Role of Diffusion-weighted and Contrast-enhanced Magnetic Resonance Imaging in Differentiating Activity of Ankylosing Spondylitis. <i>Chin Med J (Engl).</i> 2017; <b>130</b>(11): 13038. <a target=xrefwindow id=d757e3968 href="http://www.ncbi.nlm.nih.gov/pubmed/28524829">PubMed Abstract </a> | <a target=xrefwindow id=d757e3971 href="http://dx.doi.org/ 10.4103/0366-6999.206359">Publisher Full Text </a> | <a target=xrefwindow id=d757e3975 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455039">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727629211">F1000 Recommendation</a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d757e3989 class=n-a></a>Bradbury LA, Hollis KA, Gautier B, <i> et al.</i>: Diffusion-weighted Imaging Is a Sensitive and Specific Magnetic Resonance Sequence in the Diagnosis of Ankylosing Spondylitis. <i>J Rheumatol.</i> 2018; <b>45</b>(6): 7718. <a target=xrefwindow id=d757e4000 href="http://www.ncbi.nlm.nih.gov/pubmed/29449501">PubMed Abstract </a> | <a target=xrefwindow id=d757e4003 href="http://dx.doi.org/10.3899/jrheum.170312">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d757e4012 class=n-a></a>Weber U, Pedersen SJ, stergaard M, <i> et al.</i>: Can erosions on MRI of the sacroiliac joints be reliably detected in patients with ankylosing spondylitis? - A cross-sectional study. <i>Arthritis Res Ther.</i> 2012; <b>14</b>(3): R124. <a target=xrefwindow id=d757e4023 href="http://www.ncbi.nlm.nih.gov/pubmed/22626458">PubMed Abstract </a> | <a target=xrefwindow id=d757e4026 href="http://dx.doi.org/10.1186/ar3854">Publisher Full Text </a> | <a target=xrefwindow id=d757e4030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3446505">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730454837"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e4039 class=n-a></a>Laloo F, Herregods N, Varkas G, <i> et al.</i>: MR signal in the sacroiliac joint space in spondyloarthritis: a new sign. <i>Eur Radiol.</i> 2017; <b>27</b>(5): 202430. <a target=xrefwindow id=d757e4050 href="http://www.ncbi.nlm.nih.gov/pubmed/27651143">PubMed Abstract </a> | <a target=xrefwindow id=d757e4053 href="http://dx.doi.org/10.1007/s00330-016-4587-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730454837">F1000 Recommendation</a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726042699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d757e4066 class=n-a></a>Hu Z, Wang X, Qi J, <i> et al.</i>: Backfill is a specific sign of axial spondyloarthritis seen on MRI. <i>Joint Bone Spine.</i> 2016; <b>83</b>(2): 17983. <a target=xrefwindow id=d757e4077 href="http://www.ncbi.nlm.nih.gov/pubmed/26709251">PubMed Abstract </a> | <a target=xrefwindow id=d757e4080 href="http://dx.doi.org/10.1016/j.jbspin.2015.05.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726042699">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 21 Sep 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1512&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1512&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK<br/> <sup>2</sup> NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK<br/> <p> <div class=margin-bottom> Leticia Garcia-Montoya <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Project Administration, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Hanna Gul <br/> <span>Roles: </span> Visualization, Writing  Review & Editing </div> <div class=margin-bottom> Paul Emery <br/> <span>Roles: </span> Conceptualization, Supervision, Visualization, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1512/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 21 Sep 2018, 7:1512 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14956.1">https://doi.org/10.12688/f1000research.14956.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Garcia-Montoya L <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=16283 data-id=14956 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14956.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1512/v1/pdf?article_uuid=462243f8-93f7-46ce-8c7c-42e495053dcb" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14956.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Garcia-Montoya L, Gul H and Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1512 (<a href="https://doi.org/10.12688/f1000research.14956.1" target=_blank>https://doi.org/10.12688/f1000research.14956.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14956 id=mobile-track-article-signin-14956 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14956?target=/articles/7-1512"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16283 /> <input name=articleId type=hidden value=14956 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Nigil Haroon</strong>, Krembil Research Institute, University Health Network, University of Toronto, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Michael Ward</strong>, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 21 Sep 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1512&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1512&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=39045-38200></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=39046-38201></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1512/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>21 Sep 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Nigil Haroon</strong>, Krembil Research Institute, University Health Network, University of Toronto, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael Ward</strong>, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1512&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1512/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in ankylosing spondylitis:...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1512/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1512/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1512/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Garcia-Montoya L et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1512/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1512",
            templates : {
                twitter : "Recent advances in ankylosing spondylitis: understanding the.... Garcia-Montoya L et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1512/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in ankylosing spondylitis: understanding the disease and management", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in ankylosing spondylitis: understanding the disease and management", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14956/16283")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "16283");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "38200": 0,
                           "38201": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "2af3c843-f876-44b8-84c0-2e07be84b4fb";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1512.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1512.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1512.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1512.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1512.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>